Stabilizing Plasmodium falciparum proteins for small molecule drug discovery
Protein Science · 2026-06 · 35 (6)
DOI: 10.1002/pro.70614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 02.05.2026. Verfasst von Marius Amann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Pharmazeutische Wissenschaften, Albert-Ludwigs-Universität Freiburg, Freiburg i. Br, Germany. Hauptthemen laut MEDLINE: Plasmodium falciparum, Protozoan Proteins, Drug Discovery, Antimalarials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Early‐stage drug discovery relies on the availability of stable protein for reliable biophysical characterization of ligand binding. However, many Plasmodium falciparum proteins are challenging to produce in heterologous systems, which limits their experimental utility. To address this, we tested whether ProteinMPNN‐guided sequence design could generate stabilized surrogate constructs that retain wild‐type‐like structure and binding thermodynamics. Designs were generated with constraints to maintain conserved and binding‐site residues for three therapeutically relevant targets: Pf BDP1‐BRD, Pf BDP4‐BRD, and Pf K13‐KREP. The resulting constructs showed markedly increased thermal stability. Using Pf BDP1‐BRD as a benchmark, isothermal titration calorimetry confirmed that the stabilized variants retained wild‐type‐like binding thermodynamics with a known ligand. Extending this approach to other targets, a Pf K13‐KREP construct led to an apo structure with a binding pocket closely matching the wild type. For Pf BDP4‐BRD, virtual screening against a previously reported wild‐type crystal structure identified putative binders, while a stabilized surrogate for this otherwise unstable target enabled their experimental validation and the determination of a 1.25 Å co‐crystal structure with a newly identified inhibitor. Our findings demonstrate that computationally stabilized surrogates are practical and effective tools for robust biophysics and structure‐enabled drug discovery against otherwise challenging malaria proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut für Pharmazeutische Wissenschaften, Albert-Ludwigs-Universität Freiburg, Freiburg i. Br, Germany.
- Institut für Biochemie, Albert-Ludwigs-Universität Freiburg, Freiburg i. Br, Germany.
ORCID-Profile: Marius Amann, Tim Sträßer, Oliver Einsle, Stefan Günther
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Amann, M., Sträßer, T., Einsle, O., & Günther, S. (2026). Stabilizing Plasmodium falciparum proteins for small molecule drug discovery. Protein Science, 35(6). https://doi.org/10.1002/pro.70614
Vancouver
Amann M, Sträßer T, Einsle O, Günther S. Stabilizing Plasmodium falciparum proteins for small molecule drug discovery. Protein Science. 2026;35(6). doi:10.1002/pro.70614
BibTeX
@article{Amann2026,
author = {Amann, Marius and Sträßer, Tim and Einsle, Oliver and Günther, Stefan},
title = {Stabilizing Plasmodium falciparum proteins for small molecule drug discovery},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {6},
doi = {10.1002/pro.70614}
}
EUVIMED